Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViewPlus is a private assistive technology company that develops and sells braille embossers, tactile graphics systems, hybrid ink-and-braille printers, and related accessibility software for blind and low-vision users. The company was founded by John Gardner following work at Oregon State University on TIGER technology for variable-height tactile graphics embossing. ViewPlus serves schools, teachers of the visually impaired, accessibility professionals, and blind students and professionals globally. Its product portfolio includes braille and tactile graphics hardware, touch-enabled learning tools, and software for braille translation and tactile content creation. The business is commercial-stage and appears focused on education and accessibility rather than therapeutic drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViewPlus.